Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

Por um escritor misterioso
Last updated 30 junho 2024
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
journal club - Kidney International
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Frontiers mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccination
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Insights for Flourishing: Are mRNA Bivalent Vaccines Helpful?
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative - Shalash - 2021 - Advanced Science - Wiley Online Library
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
The unique properties of IgG4 and its roles in health and disease
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
COVID: On the lookout for new antibodies
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccination
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees - eBioMedicine

© 2014-2024 miaad.org. All rights reserved.